Eli Lilly’s Alzheimer’s treatment shows promise in early stages of disease — but safety concerns remain
July 17, 2023 at 10:15 AM EDT
Drugmaker has completed its FDA submission for approval of donanemab, with regulatory action expected by the end of this year
